Innate Pharma announces conference call for Third Quarter 2023 Business Update

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that the Company will hold a conference call on Tuesday, November 14, 2023, at 2 p.m. CET / 8 a.m. ET, to give an update on business progress during the third quarter of 2023.

Participants during the call will be: 

• Mondher Mahjoubi, Chief Executive Officer 
• Yannis Morel, Executive Vice President, Product Portfolio Strategy & Business Development 
• Sonia Quaratino, Executive Vice President, Chief Medical Officer
• Frédéric Lombard, Senior Vice President, Chief Financial Officer

*****

Details for the Third Quarter 2023 Business Update Virtual Event

Tuesday, November 14, 2023, at 2 p.m. CET / 8 a.m. ET

The live webcast will be available at the following link: 
https://events.q4inc.com/attendee/172996087
Webcast participants can use the chat tool to ask written questions during the conference.

Participants may also join via telephone to ask oral questions during the conference using the following registration link: https://registrations.events/direct/Q4E61217

This information can also be found on the Investors section of the Innate Pharma website, www.innate-pharma.com. A replay of the webcast will be available on the Company website for 90 days following the event.